UK Variant Of Coronavirus May Be Harder To Diagnose With Many Current Tests: FDA
Executive Summary
The agency is cautioning that current tests may give false negative results for patients with genetic mutations of SARS-CoV-2, making it harder to control the spread of the pandemic.
You may also be interested in...
Coronavirus Variants Spur FDA To Write New Guidance For COVID-19 Test Developers
The US agency’s immediately-in-effect guidance document – released on 22 February – explains how makers of COVID-19 diagnostics can assess whether their tests are impacted by mutations of the virus.
Gritstone Jumps Into COVID-19 Vaccine Race, Eyeing Mutant Strains
The company is developing a vaccine with both adenoviral and mRNA technology that could potentially overcome resistance mutations on the SARS-CoV-2 spike protein.
FDA Commissioner Hahn To Seek Public Health Leadership Post To Work On COVID-19 Issues Next
Outgoing US FDA chief Stephen Hahn has signaled that he’ll seek a posting in public health, where he can increase equity and help in the fight against COVID-19.